The University of Liverpool and Alder Hey Children’s NHS Foundation Trust are among UK organisations working to develop targeted treatments for juvenile idiopathic arthritis (JIA).
The Cluster (childhood arthritis and associated uveitis: stratification through endotypes and mechanism) Consortium has been awarded £5 million from the Medical Research Council with partnership funding from Arthritis Research UK.
From May 2018, the consortium will help clinicians to target specific treatments for patients.
The five-year project will analyse data captured from national trials involving JIA and JIA-uveitis patients.
The researchers hope to identify a panel of tests that clinicians can use to make sure treatments are targeted specifically to groups of patients with similar characteristics.
Cluster work stream leader, Professor Michael Beresford, highlighted: “This important and exciting collaboration promises to make a real difference to the way we care for children and young people with these debilitating conditions.”
Professor Beresford is director of the NIHR Alder Hey Clinical Research Facility and the UK’s only Experimental Arthritis Treatment Centre for Children in Liverpool.